newsfilter
← Latest News
PR Newswire·

RegeneRx Licensee Acquired by Korean Biopharmaceutical Group

ROCKVILLE, Md., Sept. 27, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB:RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration), today announced that GtreeBNT, the licensee fo